Cadence Biomedical, headquartered in Seattle, WA, is an early stage medical device company that is committed to helping the 2.3 million Americans who suffer severe mobility impairments to gain a more mobile and independent life.
The company is currently developing a new class of device, a kinetic orthosis, based on a novel exotendon technology invented at the Cleveland Clinic by world-renowned researcher Dr. A.J. van den Bogert. Cadence closed its first round of funding in August 2010 (as Empowering Engineering Technologies, Corp.) and signed a perpetual, worldwide exclusive license agreement with the Cleveland Clinic to develop and market the technology. Market release of the kinetic orthosis are expected in early 2012.
Funding Rounds (3) - $3.05MUpdate
Current Team (4)Update
Board Members and Advisors (3)Update
|Dec 9, 2015||Business Wire - Published Study Demonstrates Kickstart® Effectiveness for Restoring Walking Ability|
|Dec 9, 2015||Med City News - Spring-based wearable device could help those with certain neurological conditions walk again|
|Oct 7, 2015||Business Wire - Cadence Biomedical, University of Nebraska Omaha Announce Research Collaboration|
|Aug 17, 2015||Business Wire - Cadence Biomedical, Université de Montréal Announce Research Grant from Canadian Physiotherapy Association|
|Jun 24, 2015||GeekWire - Cadence Biomedical raises $1.2M to help people with disabilities restore walking ability - GeekWire|
|May 30, 2013||GeekWire - Cadence receives $1 million defense grant to get wounded soldiers walking again|
|May 30, 2013||Xconomy - Cadence Biomedical Nets $1M, Loads of Press, for Walk-Assist Device|
|May 22, 2013||GeekWire - From shopping advice to walking devices, startups with UW ties show off their successful ideas|
146 N. Canal St
Seattle, Washington 98103